PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
253.38%
Some net income increase while CNQ is negative at -56.71%. John Neff would see a short-term edge over the struggling competitor.
1.63%
Less D&A growth vs. CNQ's 19.91%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-50.59%
Negative yoy deferred tax while CNQ stands at 178.26%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-48.89%
Both cut yoy SBC, with CNQ at -35.71%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-73.91%
Negative yoy working capital usage while CNQ is 116.09%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
202.94%
AR growth of 202.94% while CNQ is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-150.00%
Negative yoy usage while CNQ is 116.09%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-97.87%
Negative yoy while CNQ is 124.29%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-46.73%
Negative yoy CFO while CNQ is 33.15%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-13.03%
Both yoy lines negative, with CNQ at -19.63%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-637.50%
Negative yoy acquisition while CNQ stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
714.29%
Purchases growth of 714.29% while CNQ is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-84.42%
We reduce yoy sales while CNQ is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-32.12%
Both yoy lines negative, with CNQ at -432.71%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-57.96%
Both yoy lines negative, with CNQ at -110.09%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
5.88%
Debt repayment well below CNQ's 39.38%. Michael Burry suspects heavier leverage risk or insufficient cash generation to keep pace.
-100.00%
Negative yoy issuance while CNQ is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.